The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelical Bar Regulatory News (HLCL)

Share Price Information for Helical Bar (HLCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 209.50
Bid: 210.50
Ask: 214.50
Change: 4.00 (1.95%)
Spread: 4.00 (1.90%)
Open: 210.00
High: 211.00
Low: 206.50
Prev. Close: 205.50
HLCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Aug 2018 17:37

RNS Number : 6686X
Helical PLC
13 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Helical Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

JPMorgan Chase & Co.

City and country of registered office (if applicable)

Wilmington, Delaware, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

J.P. Morgan Securities Plc

JPMorgan Chase Bank, National Association

City and country of registered office (if applicable)

London, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

09 August 2018

6. Date on which issuer notified (DD/MM/YYYY):

13 August 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.99%

0.90%

5.89%

119,363,349

Position of previous notification (if

applicable)

5.07%

0.85%

5.93%

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B0FYMT95

5,960,152

4.99%

SUBTOTAL 8. A

5,960,152

4.99%

 

 

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Convertible Bond

17/06/2019

N/A

1,006,158

0.84%

SUBTOTAL 8. B 1

1,006,158

0.84%

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

Cash-settled Equity Swap

30/04/2019

Cash

1,382

0.00%

Cash-settled Equity Swap

17/06/2019

Cash

9,787

0.01%

Cash-settled Equity Swap

11/09/2019

Cash

3,690

0.00%

Cash-settled Equity Swap

13/02/2020

Cash

54,215

0.05%

SUBTOTAL 8.B.2

69,074

0.06%

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association

J.P. Morgan International Finance Limited

J.P. Morgan Capital Holdings Limited

J.P. Morgan Securities plc

4.99%

5.89%

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

 

11. Additional informationxvi

 

 

Chain of controlled undertakings:

 

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Securities plc (100%)

 

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

 

Place of completion

London, United Kingdom

Date of completion

13 August 2018

Notes

 

i Please note that national forms may vary due to specific national legislation (Article 3(1a) of Directive 2004/109/EC) as for instance the applicable thresholds or information regarding capital holdings.

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h)/ Article 10 (b) to (h) of Directive 2004/109/EC; (c) all parties to the agreement referred to in Article 10 (a) of Directive 2004/109/EC (DTR5.2.1 (a)) or (d) the holder of financial instruments referred to in Article 13(1) of Directive 2004/109/EC (DTR5.3.1).

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in points (b) to (h) of Article 10 of Directive 2004/109/EC (DTR5.2.1 (b) to (h)), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in letter (b) of Article 10 of that Directive (DTR5.2.1 (b)), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in letter (c) of Article 10 of that Directive (DTR5.2.1 (c)), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in letter (d) of Article 10 of that Directive (DTR5.2.1 (d)), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in letter (e) of Article 10 of that Directive (DTR5.2.1 (e)), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under Article 9 (DTR 5.1), under letters (a) to (d) of Article 10 of that Directive (DTR5.2.1 (a) to (d)) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in letter (f) of Article 10 of that Directive (DTR5.2.1 (f)), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in letter (g) of Article 10 of that Directive (DTR5.2.1 (g)), the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in letter (h) of Article 10 of that Directive (DTR5.2.1 (h)), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in Article 10 (b) to (h) of Directive 2004/109/EC (DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to in Article 10 of that Directive (DTR5.2) unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the lowest applicable threshold in accordance with national law, please note that it might not be necessary in accordance with national law to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (Article 13(1a) of Directive 2004/109/EC) (DTR 5.3.3.A).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only thus the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain leaving a row free between different chains (e.g.: A, B, C, free row, A, B, D, free row, A, E, F etc.).

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLFKNDNABKDPFD
Date   Source Headline
22nd Apr 20247:00 amRNSTrading Update
4th Apr 202410:00 amRNSListing Rule 9.6.14(2) Disclosure
25th Mar 20247:00 amRNSHELICAL AGREES SALE OF 25 CHARTERHOUSE SQUARE
15th Mar 20247:00 amRNSThree Crowns signs lease at The JJ Mack Building
14th Mar 20244:31 pmRNSDirector/PDMR Shareholding
8th Feb 20249:15 amRNSChanges to Board and Committee Composition
23rd Jan 20243:59 pmRNSDirector/PDMR Shareholding
16th Jan 202411:09 amRNSDirector/PDMR Shareholding
15th Jan 202410:27 amRNSMajor Shareholding Notification
11th Jan 20244:06 pmRNSMajor Shareholding Notification
9th Jan 20247:00 amRNSTrading Update
6th Dec 20238:34 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSSainsbury's signs lease at The JJ Mack Building
30th Nov 20233:57 pmRNSHolding(s) in Company
29th Nov 20232:53 pmRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSHalf-year Report
1st Nov 202312:28 pmRNSWeWork Update
13th Sep 20235:15 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20238:00 amRNSNotice of Results
1st Aug 20237:00 amRNSNotification of Interests of Directors and PDMRs
19th Jul 20232:41 pmRNSHolding(s) in Company
13th Jul 202311:36 amRNSResult of AGM
13th Jul 20237:00 amRNSTrading Update
12th Jul 20237:00 amRNSHelical signs contract for office portfolio JV
20th Jun 20237:00 amRNSDirector/PDMR Shareholding
13th Jun 20237:00 amRNSNotice of AGM & 2023 Annual Report & Accounts
7th Jun 202310:09 amRNSHolding(s) in Company
2nd Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20234:46 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSAnnual Results for the Year to 31 March 2023
27th Apr 202311:27 amRNSHolding(s) in Company
24th Apr 20239:18 amRNSDirector Declaration
6th Apr 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
27th Mar 20238:00 amRNSNotice of Results
15th Mar 20234:05 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:43 pmRNSHolding(s) in Company
15th Feb 202312:07 pmRNSHelical selected as preferred office JV partner
17th Jan 20239:28 amRNSDirector/PDMR Shareholding
7th Dec 20224:35 pmRNSDirector/PDMR Shareholding
29th Nov 20229:28 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
14th Nov 202210:05 amRNSMajor Shareholding Notification
14th Nov 20227:00 amRNSFIRST LETTING AT THE JJ MACK BUILDING
11th Nov 202210:27 amRNSMajor Shareholding Notification
24th Oct 20227:00 amRNSTrading Update
12th Oct 202211:46 amRNSNotification under Listing Rule 9.6.14 (2)
13th Sep 20222:26 pmRNSDirector/PDMR Shareholding
9th Sep 20229:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.